Literature DB >> 29635253

Prophylactic Chorioretinectomy in Open Ocular Trauma: A Series of 36 Eyes.

Sílvia Monteiro, Angelina Meireles.   

Abstract

PURPOSE: The aim of this paper was to report the outcomes of prophylactic chorioretinectomy in open-globe injuries where a foreign body penetrated the choroid or perforated the globe.
METHODS: We conducted a retrospective, consecutive, noncomparative, and descriptive study of patients registered in the ocular trauma database between January 2006 and December 2014, who underwent vitrectomy with chorioretinectomy.
RESULTS: Thirty-six patients (33 male, 3 female) with a mean age of 40 years and a median of follow-up of 13 months were included. Twenty-one cases had penetrating globe injuries with an intraocular foreign body and 15 cases had perforating globe injuries. A concomitant chorioretinectomy was performed in all eyes, although it was only partial in 8 eyes. At the end of follow-up, proliferative vitreoretinopathy (PVR) rates were 6.5%, anatomical success was 80.6%, and the globe survival rate was 96.8%.
CONCLUSION: Prophylactic chorioretinectomy is a surgical procedure that may decrease posttraumatic PVR, thus improving final visual acuity and increasing globe survival rates.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Ocular trauma; Proliferative vitreoretinopathy; Vitrectomy

Mesh:

Substances:

Year:  2018        PMID: 29635253     DOI: 10.1159/000486549

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  2 in total

Review 1.  [Fireworks injuries of the eye: an overview of current diagnostic and treatment options].

Authors:  A Wolf; W Schrader; H Agostini; A Gabel-Pfisterer
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

2.  Internal Limiting Membrane Peeling versus Nonpeeling to Prevent Epiretinal Membrane Formation following Vitrectomy for Posterior Segment Open-Globe Injury.

Authors:  Wen-Long Wei; Zhong Lin; Ming-Na Xu; Ke-Mi Feng; Zhen-Quan Zhao
Journal:  J Ophthalmol       Date:  2021-08-28       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.